The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...

Arango today announced that PSI CRO, a global clinical research organization, has reduced clinical trial site identification from up to six weeks to minutes using SYNETIC™, an AI-enabled knowledge ...

Kymera Therapeutics Inc. (NASDAQ:KYMR) is one of the most promising stocks under $100 to buy. On March 10, Kymera ...

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...

Innovative Medical Equipment, LLC (IME), manufacturer of the ThermaZone® thermal therapy device, announced the publication of ...

The newly introduced AI-powered study build engine marks the first phase of ClinCapture's broader intelligent trial roadmap. By automating protocol translation, Captivate establishes a foundation for ...

In the last decade, the volume of clinical trial data has surged, presenting unprecedented challenges for sponsors and contract research organizations (CROs). The task of collecting, cleaning, ...

(Nasdaq: BDSX), a leading diagnostics solutions company, announced the publication of the largest lung nodule biomarker clinical validation study ever conducted. This milestone strengthens the ...

New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures The research assesses how protocol design ...

Additional biomarker analysis reveals higher CSF levels of DOPA decarboxylase (DDC – an emerging PD biomarker) at baseline with a reduction following 90 days of dosing with GT-02287 in individuals ...

A powerful new real-world data platform could transform how scientists predict and understand Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD), reports a new study at Columbia ...